← Evidence map

ArticleJournal of thoracic disease2016

Tumor heterogeneity on (18)F-FDG-PET/CT for response monitoring in non-small cell lung cancer treated with erlotinib.

Matthijs H van Gool et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2016

2017

2018

2019

2020

this paperpooled itcites it

Tumor heterogeneity on (18)F-FDG-PET/CT for response monitoring in non-small cell lung cancer treated with erlotinib. | OpenQuestion